Skip to main content

Table 3 Comparing groups of patients with or without pulmonary HTN regarding comorbidities and sleep study parameters (n = 100)

From: Correlation between serum uric acid and pulmonary arterial hypertension based on echo probability in patients with obstructive sleep apnea syndrome

 

Total (n = 100)

Pulmonary HTN

Test of sig

p

No (n = 22)

Yes (n = 78)

No

%

No

%

No

%

DM

 No

24

24.0

6

27.3

18

23.1

χ2 = 0.166

0.684

 Yes

76

76.0

16

72.7

60

76.9

HTN

 No

20

20.0

8

36.4

12

15.4

χ2 = 4.720*

FEp = 0.039*

 Yes

80

80.0

14

63.6

66

84.6

History of DVT

 No

94

94.0

18

81.8

76

97.4

χ2 = 7.421*

FEp = 0.020*

 Yes

6

6.0

4

18.2

2

2.6

Apnea hypopnea index

 Min.–max

7.70–55.0

7.70–51.30

16.80–55.0

t = 2.940*

0.004*

 Mean ± SD

31.93 ± 11.78

25.65 ± 13.42

33.70 ± 10.71

 Median (IQR)

32.0 (22.0 – 39.0)

26.70 (11.30–34.0)

35.0 (26.10–41.0)

ODI

 Min.–max

1.70–60.0

1.70 31.90

13.70–60.0

U = 666.0

0.110

 Mean ± SD

22.21 ± 13.89

16.32 ± 10.72

23.87 ± 14.28

 Median (IQR)

18.60 (16.10–20.80)

15.0 (7.80–27.0)

18.60 (16.30–20.60)

t90%

 Min.–max

0.0–38.0

0.0–11.90

0.0–38.0

U = 308.0*

 < 0.001*

 Mean ± SD

7.17 ± 8.90

1.94 ± 3.66

8.65 ± 9.39

 Median (IQR)

5.30 (0.90–9.80)

0.10 (0.0–1.30)

6.40 (2.50–11.20)

  1. IQR Interquartile range, SD Standard deviation, t Student t-test, U Mann–Whitney test, χ2 chi-square test, FE Fisher exact, p p-value for comparing between different categories
  2. *Statistically significant at p ≤ 0.05